Meditor Group’s Merck MRK Stock Holding History

Meditor Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-1,830,437	Closed	-$83.2M	–	17
2013 Q3	$83.2M	Sell	1,830,437 -125,760	-6%	-$5.74M	11.73%	1
2013 Q2	$86.7M	Buy	+1,956,197	New	+$87.4M	11.74%	1

Other funds holding MRK

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Meditor Group's MRK Position: Q4 2013 in Review

Meditor Group sold out of Merck (MRK) in Q4 2013, closing a stake of 1,830,437 shares — an estimated $83.2M sold.

Meditor Group first reported a position in MRK in Q2 2013 and held it in 2 quarters. The position peaked at $86.7M in Q2 2013. 1,566 funds tracked by Wall St. Rank hold MRK as of Q4 2013.

Meditor Group reported no remaining Merck position as of Q4 2013 after selling out during the quarter.
Meditor Group sold 1,830,437 Merck shares in Q4 2013, an estimated $83.2M.
Meditor Group first reported a position in Merck in Q2 2013 and held it in 2 quarters.
Meditor Group's Merck position peaked at $86.7M in Q2 2013.
1,566 funds tracked by Wall St. Rank held Merck as of Q4 2013.

Based on Meditor Group's 13F filing for Q4 2013, filed 21 Jan 2014.